An Adjunctive Use Of Asfotase Alfa and Zoledronic Acid After Spinal Surgery In Neurofibromatosis Type 1 Related Dystrophic Scoliosis
ABSTRACT: Objective: Dystrophic scoliosis is a serious skeletal manifestation of neurofibromatosis 1 (NF1). The condition requires surgical intervention that is frequently associated with poor outcome due to the high rate of impaired bone healing, pseudoarthrosis, and loosening of the spinal instru...
Main Authors: | Tasma Harindhanavudhi, MD, Takashi Takahashi, MD, Anna Petryk, MD, David W. Polly, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | AACE Clinical Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2376060520306337 |
Similar Items
-
Adult-Onset Hypophosphatasia: Before and After Treatment with Asfotase ALFA
by: Angela L. Magdaleno, DO, et al.
Published: (2019-11-01) -
Pathophysiology of hypophosphatasia and the potential role of asfotase alfa
by: Orimo H
Published: (2016-05-01) -
Visualization of asfotase alfa-binding to sites of calcification in vivo
by: Flavia Amadeu de Oliveira, et al.
Published: (2020-10-01) -
Physical Function and Health‐Related Quality of Life in Adults Treated With Asfotase Alfa for Pediatric‐Onset Hypophosphatasia
by: Franca Genest, et al.
Published: (2020-09-01) -
Dystrophic Scoliosis in Neurofibromatosis and Rib-head Resection: A Case Report
by: Chong KL, et al.
Published: (2017-11-01)